Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trialOnyema Ogbuagu, Jason Flamm, Peter Ruane et al.|The Lancet HIV|2021Cited by 91
Immunosuppression among HIV‐1‐positive patients attending for care: experience from two large HIV centres in the United KingdomDerval Harte, Robert F. Miller, Annemiek de Ruiter et al.|HIV Medicine|2009Cited by 11